SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-20-307966
Filing Date
2020-12-02
Accepted
2020-12-02 09:30:58
Documents
1
Effectiveness Date
2020-12-02

Document Format Files

Seq Description Document Type Size
1 S-8 POS d290840ds8pos.htm S-8 POS 18848
  Complete submission text file 0001193125-20-307966.txt   19831
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-36485 | Film No.: 201362545
SIC: 2834 Pharmaceutical Preparations